Development and evaluation of human AP endonuclease inhibitors in melanoma and glioma cell lines

Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers

(2010) A Al-Attar et al.   BRITISH JOURNAL OF CANCER

Human AP endonuclease 1 (APE1): From mechanistic insights to druggable target in cancer

(2010) Rachel Abbotts et al.   CANCER TREATMENT REVIEWS

Essential Role of DNA Base Excision Repair on Survival in an Acidic Tumor Microenvironment

(2009) Y. Seo et al.   CANCER RESEARCH

The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies

(2009) D. Gu et al.   MUTAGENESIS

Identification and Characterization of Inhibitors of Human Apurinic/apyrimidinic Endonuclease APE1

(2009) Anton Simeonov et al.   PLoS One

MiTF Regulates Cellular Response to Reactive Oxygen Species through Transcriptional Regulation of APE-1/Ref-1

(2008) Feng Liu et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Pharmacophore Guided Discovery of Small-Molecule Human Apurinic/Apyrimidinic Endonuclease 1 Inhibitors

(2008) Zahrah Zawahir et al.   JOURNAL OF MEDICINAL CHEMISTRY

HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair

(2008) T. T. Koll et al.   MOLECULAR CANCER THERAPEUTICS